Serina Therapeutics Inc Cash Flow Quality Index
Serina Therapeutics Inc cash flow quality index. Serina Therapeutics Inc (SER) has a Cash Flow Quality Index of -2.14x as of September 2024. Operating cash flow of $-2.96 Million is below net income of $1.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Serina Therapeutics Inc (SER) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Serina Therapeutics Inc (2023–2023)
Cash flow quality index of Serina Therapeutics Inc from 2023 to 2023. Historical Cash Flow Quality Index for Serina Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Serina Therapeutics Inc to measure how much of total assets are equity-financed.
Serina Therapeutics Inc Cash Flow Quality Index by Year (2023–2023)
Serina Therapeutics Inc cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Serina Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Serina Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.47x | $-2.48 Million | $5.27 Million | — |